GSK PLC (GSK)
41.24
+0.66
(+1.61%)
USD |
NYSE |
Apr 23, 15:58
GSK Net Income (Quarterly): 434.69M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 434.69M |
September 30, 2023 | 1.854B |
June 30, 2023 | 2.033B |
March 31, 2023 | 1.811B |
December 31, 2022 | 1.758B |
September 30, 2022 | 12.74B |
June 30, 2022 | 1.053B |
March 31, 2022 | 2.418B |
December 31, 2021 | 295.22M |
September 30, 2021 | 1.886B |
June 30, 2021 | 1.950B |
March 31, 2021 | 1.479B |
December 31, 2020 | 893.26M |
September 30, 2020 | 1.608B |
June 30, 2020 | 2.806B |
March 31, 2020 | 2.006B |
December 31, 2019 | 1.673B |
September 30, 2019 | 1.912B |
June 30, 2019 | 1.239B |
March 31, 2019 | 1.081B |
December 31, 2018 | 1.563B |
September 30, 2018 | 1.847B |
June 30, 2018 | 600.96M |
March 31, 2018 | 763.39M |
December 31, 2017 | -725.04M |
Date | Value |
---|---|
September 30, 2017 | 1.587B |
June 30, 2017 | -230.10M |
March 31, 2017 | 1.296B |
December 31, 2016 | 319.24M |
September 30, 2016 | 1.061B |
June 30, 2016 | -624.85M |
March 31, 2016 | 403.69M |
December 31, 2015 | -536.96M |
September 30, 2015 | 833.66M |
June 30, 2015 | 228.23M |
March 31, 2015 | 12.26B |
December 31, 2014 | 1.634B |
September 30, 2014 | 669.49M |
June 30, 2014 | 1.101B |
March 31, 2014 | 1.105B |
December 31, 2013 | 3.984B |
September 30, 2013 | 1.503B |
June 30, 2013 | 1.605B |
March 31, 2013 | 1.493B |
December 31, 2012 | 1.361B |
September 30, 2012 | 1.745B |
June 30, 2012 | 1.960B |
March 31, 2012 | 2.055B |
December 31, 2011 | 1.967B |
September 30, 2011 | 2.219B |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
295.22M
Minimum
Dec 2021
12.74B
Maximum
Sep 2022
2.202B
Average
1.811B
Median
Mar 2023
Net Income (Quarterly) Benchmarks
AstraZeneca PLC | 960.00M |
Haleon PLC | -3.726M |
Novo Nordisk A/S | 3.170B |
Pfizer Inc | -3.369B |
Sanofi SA | -597.68M |
Net Income (Quarterly) Related Metrics
Revenue (Quarterly) | 10.00B |
Total Expenses (Quarterly) | 8.544B |
EPS Diluted (Quarterly) | 0.2111 |
Enterprise Value | 97.28B |
Gross Profit Margin (Quarterly) | 69.97% |
Profit Margin (Quarterly) | 4.35% |
Earnings Yield | 6.78% |
Operating Earnings Yield | 10.16% |
Normalized Earnings Yield | 7.417 |